Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) shares rose 5.4% during mid-day trading on Tuesday . The company traded as high as $10.65 and last traded at $10.65. Approximately 206,199 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 551,962 shares. The stock had previously closed at $10.10.
Cybin Trading Down 4.7 %
The stock has a market cap of $1.42 billion and a price-to-earnings ratio of -39.83. The stock has a fifty day simple moving average of $10.17 and a 200-day simple moving average of $5.67.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Recommended Stories
- Five stocks we like better than Cybin
- Differences Between Momentum Investing and Long Term Investing
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Dividend Capture Strategy: What You Need to Know
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Consumer Staples Stocks, Explained
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
